Use of minigene systems to dissect alternative splicing elements

被引:171
作者
Cooper, TA
机构
[1] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
minigene; deletion analysis; RNA binding; exon splicing enhancer; exon splicing silencer; intronic splicing enhancer; intronic splicing silencer;
D O I
10.1016/j.ymeth.2005.07.015
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pre-mRNA splicing is an essential step for gene expression in higher eukaryotes. The splicing efficiency of individual exons is determined by multiple features involving gene architecture, a variety of cis-acting elements within the exons and flanking introns, and interactions with components of the basal splicing machinery (called the spliceosome) and auxiliary regulatory factors which transiently co-assemble with the spliceosome. Both alternative and constitutive exons are recognized by multiple weak protein:RNA interactions and different exons differ in the interactions which are determinative for exon usage. Alternative exons are often regulated according to cell-specific patterns and regulation is mediated by specific sets of cis-acting elements and trans-acting factors. Transient expression of minigenes is a commonly used in vivo assay to identify the intrinsic features of a gene that control exon usage, identify specific cis-acting elements that control usage of constitutive and alternative exons, identify cis-acting elements that control cell-specific usage of alternative exons, and once regulatory elements have been identified, to identify the trans-acting factors that bind to these elements and modulate splicing. This chapter describes approaches and strategies for using minigenes to define the cis-acting elements that determine splice site usage and to identify and characterize the trans-acting factors that bind to these elements and regulate alternative splicing. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:331 / 340
页数:10
相关论文
共 36 条
[21]  
KRAWCZAK M, 1992, HUM GENET, V90, P41
[22]  
Ladd AN, 2002, GENOME BIOL, V3
[23]   The evolving roles of alternative splicing [J].
Lareau, LF ;
Green, RE ;
Bhatnagar, RS ;
Brenner, SE .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2004, 14 (03) :273-282
[24]  
LIBRI D, 1989, NUCLEIC ACIDS RES, V17, P6449
[25]   A ROLE FOR EXON SEQUENCES IN ALTERNATIVE SPLICING OF THE HUMAN FIBRONECTIN GENE [J].
MARDON, HJ ;
SEBASTIO, G ;
BARALLE, FE .
NUCLEIC ACIDS RESEARCH, 1987, 15 (19) :7725-7733
[26]  
RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898
[27]  
Ryan KJ, 1996, MOL CELL BIOL, V16, P4014
[28]   Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy [J].
Savkur, RS ;
Philips, AV ;
Cooper, TA .
NATURE GENETICS, 2001, 29 (01) :40-47
[29]   Silencer elements as possible inhibitors of pseudoexon splicing [J].
Sironi, M ;
Menozzi, G ;
Riva, L ;
Cagliani, R ;
Comi, GP ;
Bresolin, N ;
Giorda, R ;
Pozzoli, U .
NUCLEIC ACIDS RESEARCH, 2004, 32 (05) :1783-1791
[30]   The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4 [J].
Stickeler, E ;
Fraser, SD ;
Honig, A ;
Chen, AL ;
Berget, SM ;
Cooper, TA .
EMBO JOURNAL, 2001, 20 (14) :3821-3830